Isoguvacine; isoguvacine; 1,2,3,6-tetrahydropyridine-4-carboxylic acid; 64603-90-3; 1,2,3,6-Tetrahydro-pyridine-4-carboxylic acid; 1,2,3,6-Tetrahydro-4-pyridinecarboxylic acid; UNII-YTF580771Y; CHEMBL39071; CHEBI:34799; YTF580771Y; 4-Pyridinecarboxylic acid, 1,2,3,6-tetrahydro-; AC1OEMUS; 1,2,3,6-tetrahydropyridinium-4-carboxylate; 1,2,3,6-tetrahydropyridin-1-ium-4-carboxylate; Tocris-0235; Spectrum_001974; Lopac-G-002; AC1L1GNT; Spectrum3_001869; Biomol-NT_000254; AC1Q5QG1; Lopac0_000561; KBioSS_002540; BSPBio_003318; DivK1c_000115

6-Aminohexanoic acid; 6-aminohexanoic acid; 6-Aminocaproic acid; aminocaproic acid; 60-32-2; amicar; Epsikapron; Caprocid; Capramol; Epsamon; EACA; Caprolisin; Acepramin; Hemocaprol; Epsicapron; Respramin; Amikar; EPSILON-AMINOCAPROIC ACID; Hexanoic acid, 6-amino-; Epsilcapramin; Aminokapron; Caplamin; Acepramine; Capracid; Hemopar; Ipsilon; Afibrin; Atsemin; Hepin; Epsilon S; Aminocaproic; Capralense; epsilon-Leucine; EACS; epsilon-Norleucine; epsilcapramine; 6-Amino-n-hexanoic acid; omega-Aminocaproic acid; epsilon-Aminohexanoic acid; 6-amino-hexanoic acid; ACS; Amicar; Aminocaproate; Capranol; Caproamin; Epsicaprom; Epsilcapramine; Hemopar;Hepin; Acide aminocaproique; Acide aminocaproique [French]; Acide aminocaproque; Acido aminocaproico; Acidum aminocaproicum; Acidum aminocaproicum [Latin]; Aminocaproic Acid In Plastic Container; Aminocaproic Acids; Aminohexanoic acid; Eaca kabi; Epsilon Aminocaproic Acid; A 7824; CL 10304; CY 116; CY116; JD 177; Acide aminocaproique [INN-French]; Acido aminocaproico [DCIT,Spanish]; Acido aminocaproico [INN-Spanish]; Acidum aminocaproicum [INN-Latin]; Amicar (TN); Aminocaproic acid (USP); CL-10304; CY-116; Epsilon-Ahx; Epsilon-Aminocaproic acid; Epsilon-Aminocapronsaeure; Epsilon-Aminohexanoic acid; Epsilon-Leucine; Epsilon-Norleucine; Epsilon-aminocaproate; Epsilon-aminocapronzuur; Fullevir (TN); Kyselina omega-aminokapronova; Kyselina omega-aminokapronova [Czech]; Omega-Aminocaproic acid; Omega-Aminohexanoic acid; S04-0132; Acid, 6-Aminocaproic; Acid, 6-Aminohexanoic; Acid, epsilon-Aminocaproic; Aminocaproic acid (USP/INN); Aminocaproic acid [USAN:BAN:INN]; Aminocaproic acid [USAN:INN:BAN]; Epsilon-Aminocaproic acid (JAN); HEXANOIC ACID,6-AMINO; Epsilon-Amino-n-caproic acid; Epsilon-Amino-n-hexanoic acid; Amicar, A-amino caproic acid, A-Ahx, 6-aminohexanoic acid, Aminocaproic acid; 6 Aminocaproic Acid; 6 Aminohexanoic Acid; 6-amino-n-caproate; 6-amino-n-caproic acid; 6-aminohexanoate; 6-Amino Hexanoic Acid

Anetamin; GHB; Hydroxyb; Oxybate; SHB; Somsanit; Xyrem; Gamma OH; Oxybate sodium; Utyric acid monosodium salt; EB 27; WY 3478; Gam-OH; Gamma-Hydroxy butyrate; Gamma-Hydroxy sodium butyrate; Gamma-Hydroxybutanoic acid; Gamma-Hydroxybutyrate sodium; Gamma-Hydroxybutyric acid; Gamma-Hydroxybutyric acid decomposition product; Gamma-Hydroxybutyric acid monosodium salt; Gamma-OH; Xyrem (TN); Gamma-Hydroxybutyric acid, sodium salt; Oxy-n-butyric acid; Sodium Oxybate (4-hydroxybutanoic acid); Sodium .gamma.-hydroxybutyrate; Sodium .gamma.-oxybutyrate; AA3E2AF0-AB7A-4A1E-A391-199C049D7162; Butanoic acid, 4-hydroxy-, monosodium salt; Butanoic acid, 4-hydroxy-, sodium salt; Butyric acid, 4-hydroxy-, monosodium salt; Butyric acid, 4-hydroxy-, sodium salt; 3-carboxypropoxy acid; 4 HB; 4-Hydroxy; 4-Hydroxyacid; 4-Hydroxyalkanoic acid; 4-Hydroxybutanoic acid; 4-Hydroxybuttersaeure; 4-Hydroxybutyrate sodium; 4-Hydroxybutyric acid; 4-Hydroxybutyric acid monosodium salt; 4-Hydroxycarboxylic acid; 4-OHB; 4-hydroxy-butyric acid

D-serine; 312-84-5; (R)-2-amino-3-hydroxypropanoic acid; (2R)-2-amino-3-hydroxypropanoic acid; Serine D-form; (R)-Serine; Serine, D-; d-(+)-serine; D-2-Amino-3-hydroxypropionic Acid; D-Serin; D-Ser; UNII-1K77H2Z9B1; EINECS 206-229-4; MFCD00004269; NSC 77689; (2R)-2-amino-3-hydroxy-propanoic acid; AI3-18476; CHEMBL285123; CHEBI:16523; MTCFGRXMJLQNBG-UWTATZPHSA-N; 1K77H2Z9B1; (R)-2-Amino-3-hydroxypropionic acid; DSN; NCGC00094363-03; D-Serine, 98%; D-2-Amino-3-hydroxypropanoic acid; NSC77689; serine d-; [3h]-d-serine; (2R)-serine

Creatine; ALS-02; ALS-05; ALS-08; HD-02; PD-02; PD-04; PD-06; Creatine (ALS), Avicena; Creatine (amyotrophic lateral sclerosis), Avicena; PD-01, Avicena; AL-02 (ALS), Avicena; AL-08 (ALS), Avicena; Creatine (Huntington's disease), Avicena; Creatine (Parkinson's disease), Avicena

Alzhemed; Cerebril; Homotaurine; Vivimind; LU-02659; NC-531; NC-758; Tramiprosate (stroke), Neurochem; Tramiprosate (Alzheimer's disease), Neurochem; 3APS

4-Aminobutanoic acid; 4-aminobutyric acid; GABA; gamma-aminobutyric acid; 1956/12/2; Piperidic acid; Piperidinic acid; Aminalon; Mielogen; Gammalon; Gaballon; butanoic acid, 4-amino-; Mielomade; Gammalone; Gamarex; Gammasol; Gammar; Reanal; Immu-G; gamma-amino-n-butyric acid; gamma-Aminobutanoic acid; Butyric acid, 4-amino-; Gamastan; Gammagee; Gamulin; 4-aminobutyrate; omega-Aminobutyric acid; gamma-Aminobutyric acid; 3-Carboxypropylamine; gamma-Aminobuttersaeure; 4-amino-butanoic acid; gamma-Amino butyric acid; GAMMA-AMINO-BUTANOIC ACID

Procysteine; 19771-63-2; (R)-2-Oxothiazolidine-4-carboxylic acid; (4R)-2-oxo-1,3-thiazolidine-4-carboxylic acid; L-2-Oxothiazolidine-4-carboxylic acid; L-2-Oxothiazolidine-4-carboxylate; 4-Thiazolidinecarboxylic acid, 2-oxo-, (4R)-; CCRIS 7672; Oxothiazolidine carboxylate, L-; UNII-X7063P804E; 2-Oxothiazolidine-4-carboxylate, L-; L-2-Oxo-4-thiazolidinecarboxylic acid; BRN 4179169; (R)-2-Oxo-4-thiazolidinecarboxylic acid; (4R)-2-oxo-4-thiazolidinecarboxylic acid; CHEMBL442218; 4-Thiazolidinecarboxylic acid, 2-oxo-, L-

52-90-4; Cystein; Half-cystine; (R)-Cysteine; Thioserine; (R)-2-Amino-3-mercaptopropanoic acid; L-(+)-Cysteine; L-Cystein; (2R)-2-amino-3-sulfanylpropanoic acid; beta-Mercaptoalanine; Half cystine; FREE CYSTEINE; Cysteine, L-; L-Cys; L-Alanine, 3-mercapto-; L-Zystein; H-Cys-OH; Cisteinum [Latin]; L-2-Amino-3-mercaptopropionic acid; Cisteina [Spanish]; cisteina; Polycysteine; Cysteinum; Cisteinum; (R)-2-Amino-3-mercaptopropionic acid; L Cysteine; alpha-Amino-beta-thiolpropionic acid; L-2-Amino-3-mercaptopropanoic a

344-25-2; H-D-Pro-OH; (R)-pyrrolidine-2-carboxylic acid; (2R)-pyrrolidine-2-carboxylic acid; D-(+)-Proline; D-Prolin; R-Proline; D-Pro; H-Pros-OH; H-DPro-OH; CHEBI:16313; (R)-2-CARBOXYPYRROLIDINE; EINECS 206-452-7; (R)-PROLINE; MFCD00064317; (2R)-2-Carboxypyrrolidine; D-Pyrrolidine-2-carboxylic acid; d-2-pyrrolidinecarboxylic acid; SBB006712; 7005-20-1; D(+)-Proline, 99+%; (D)-proline; d(+)-proline; PubChem10979; D-D-Pro-OH; R)-2-Carboxypyrrolidine; AC1Q5QVZ; AC1Q71DR; AC1L1S2V; NCIStruc2_000132; NCIStruc1_001918

beta-GPA

glycocyamine; guanidinoacetate; guanidineacetic acid

2133-34-8; (S)-Azetidine-2-carboxylic acid; L-Azetidine-2-carboxylic acid; (S)-(-)-2-Azetidinecarboxylic acid; (2S)-azetidine-2-carboxylic acid; Azetidyl-2-carboxylic acid; (S)-2-Azetidinecarboxylic acid; H-Aze-OH; L-Azetidine 2-carboxylic acid; 2-Azetidinecarboxylic acid, (S)-; (S)-(-)-Azetidine-2-carboxylic acid; 2-Azetidinecarboxylic acid, L-; Azetidine-2-carboxylic acid, L-; 2-Azetidinecarboxylic acid, (2S)-; UNII-5GZ3E0L9ZU; 5GZ3E0L9ZU; L-2-Azetidinecarboxylic acid; (L)-AZETIDINE-2-CARBOXYLIC ACID; Azetidinecarboxylic a

sarcosine; 107-97-1; N-methylglycine; Sarcosinic acid; Methylglycine; Glycine, N-methyl-; Methylaminoacetic acid; 2-(methylamino)acetic acid; N-Methylaminoacetic acid; Sarcosin; (Methylamino)acetic acid; (Methylamino)ethanoic acid; Sargosine hydrochloride; N-Methyl glycine; Acetic acid, (methylamino)-; Cocoylsarcosine; Polysarcosine; N-methyl-Glycine; H-Sar-OH; UNII-Z711V88R5F; BRN 1699442; Sarcosine, 98%; AI3-15410; Methylamino-Acetic Acid; EINECS 203-538-6; SAR; CHEMBL304383; CHEBI:15611; FSYKKLYZXJSNPZ-UHFFFAOYSA-N; Z711V88R5F

alpha-(methylamino)isobutyric acid; 2-(methylamino)isobutyric acid

Isonipecotic acid; Piperidine-4-carboxylic acid; 498-94-2; 4-Piperidinecarboxylic acid; 4-Carboxypiperidine; Hexahydroisonicotinic acid; h-inp-oh; dl-isopipecolinic acid; Isonicotinic acid, hexahydro-; Acide isonipecotique; 4-Hexahydroisonicotinic acid; NSC 61049; UNII-M5TZP1RWIE; iso-nipecotic acid; Acide isonipecotique [French]; Acide piperidine-carboxylique-4; M5TZP1RWIE; EINECS 207-872-3; BRN 0112553; 4-Piperidine carboxylic acid; Acide piperidine-carboxylique-4 [French]; CHEMBL279998; SRJOCJYGOFTFLH-UHFFFAOYSA-N

beta-alanine; 107-95-9; 3-Aminopropanoic acid; 3-Aminopropionic acid; Beta Alanine; Abufene; H-beta-Ala-OH; beta-Aminopropionic acid; 2-Carboxyethylamine; .beta.-Alanine; Propanoic acid, 3-amino-; Alanine, beta-; 3-Aminopropionsaeure; beta-Ala; beta-Aminopropionsaeure; 3-Aminopropanoate; omega-Aminopropionic acid; B-ALANINE; FEMA No. 3252; 3-amino-propionic acid; beta-Alaine; AI3-18470; .beta.-Aminopropionic acid; NSC 7603; UNII-11P2JDE17B; beta-Alanine, 99%; EINECS 203-536-5; MFCD00008200; 11P2JDE17B; CHEMBL297569; CHEBI:16958; NSC7603

taurine; 2-aminoethanesulfonic acid; 107-35-7; tauphon; L-Taurine; Ethanesulfonic acid, 2-amino-; 2-Aminoethylsulfonic acid; O-Due; 2-Sulfoethylamine; taufon; Aminoethanesulfonic acid; aminoethylsulfonic acid; beta-Aminoethylsulfonic acid; 2-aminoethane-1-sulfonic acid; Taurinum [Latin]; Taurina [Spanish]; Taurine [INN]; FEMA No. 3813; CCRIS 4721; UNII-1EQV5MLY3D; NCI-C60606; AI3-18307; NSC32428; EINECS 203-483-8; NSC 32428; 1EQV5MLY3D; .beta.-Aminoethylsulfonic acid; 1-Aminoethane-2-sulfonic acid; CHEBI:15891

4-hydroxyproline

D-alanine; 338-69-2; H-D-Ala-OH; (2R)-2-aminopropanoic acid; (R)-Alanine; (R)-2-aminopropanoic acid; D-2-Aminopropionic acid; D-alpha-Alanine; Alanine, D-; Alanine D-form; D-Alanin; (R)-2-Aminopropionic acid; D-alpha-Aminopropionsaeure; (R)-2-Aminopropionsaeure; Ba 2776; D-alpha-aminopropionic acid; UNII-E3UDS4613U; D-.alpha.-Alanine; D-(-)-Alanine; CHEMBL66693; E3UDS4613U; CHEBI:15570; QNAYBMKLOCPYGJ-UWTATZPHSA-N; MFCD00008077; DAL; NCGC00024493-02; D-Alanine, 99+%; DSSTox_RID_81027; DSSTox_CID_25649; DSSTox_GSID_45649

2-Aminoisobutyric acid; 62-57-7; 2-Methylalanine; 2-Amino-2-methylpropanoic acid; H-Aib-OH; Alanine, 2-methyl-; ALPHA-AMINOISOBUTYRIC ACID; 2-Amino-2-methylpropionic acid; alpha-Methylalanine; alpha-Aminoisobutanoic acid; a-Aminoisobutyric acid; 2-amino isobutyric acid; NSC 16590; alpha,alpha-Dimethylglycine; AIB; Propionic acid, 2-amino-2-methyl-; 2-amino-isobutyric acid; 2-amino-2-methyl-propanoic acid; UNII-1E7ZW41IQU; a-Aminoisobutyrate; 2-Amino-2-methylpropanoate; .alpha.-Aminoisobutanoic acid; 2,2-dimethylglycine

1492-24-6; L-2-Aminobutyric acid; h-abu-oh; (S)-2-Aminobutanoic acid; (2S)-2-aminobutanoic acid; (S)-(+)-2-Aminobutyric Acid; L-alpha-Aminobutyric acid; L-(+)-2-aminobutyric acid; (S)-2-Aminobutyric acid; (-)-2-Aminobutyric acid; (S)-2-Amino-butyric acid; L-Butyrine; L-alpha-Amino-n-butyric acid; h-2-abu-oh; L-alpha-Aminobutyrate; Butanoic acid, 2-amino-, (2S)-; (S)-2-Aminobutanoate; 2S-amino-butanoic acid; UNII-0QAJ5KN9IM; S-Butyrine; ALPHA-AMINOBUTYRIC ACID; (2S)-2-Aminobutyric acid; L-2-Aminobuttersaeure; l(+)-2-aminobutyric a

L-serine; serine; 56-45-1; (S)-2-Amino-3-hydroxypropanoic acid; H-Ser-OH; (S)-Serine; beta-Hydroxyalanine; L-ser; L-(-)-Serine; Polyserine; Serine, L-; (2S)-2-amino-3-hydroxypropanoic acid; L-3-Hydroxy-alanine; Poly-L-serine; 2-Amino-3-hydroxypropionic acid; beta-Hydroxy-L-alanine; Serinum [Latin]; Serina [Spanish]; L-2-Amino-3-hydroxypropionic acid; Serine (VAN); L-3-Hydroxy-2-aminopropionic acid; Serine [USAN:INN]; SER (IUPAC abbrev); 3-Hydroxyalanine; L-Serin; (S)-(-)-Serine; (-)-Serine; alpha-Amino-beta-hydroxypropionic acid

l-isoleucine; Isoleucine; 73-32-5; (2S,3S)-2-Amino-3-methylpentanoic acid; H-Ile-OH; (S)-Isoleucine; 2S,3S-Isoleucine; (S,S)-Isoleucine; 2-Amino-3-methylvaleric acid; erythro-L-Isoleucine; L-(+)-Isoleucine; L-Ile; alpha-Amino-beta-methylvaleric acid; 443-79-8; Isoleucine (VAN); Isoleucinum [Latin]; Isoleucina [Spanish]; Valeric acid, 2-amino-3-methyl-; Norvaline, 3-methyl-; L-Norvaline, 3-methyl-, erythro-; ISOLEUCINE, L-; Acetic acid, amino-sec-butyl-; Pentanoic acid, 2-amino-3-methyl-; CCRIS 5229; iso-leucine

cyclopentimine; cypentil; hexazane

leucine; 61-90-5; (S)-2-Amino-4-methylpentanoic acid; H-Leu-OH; (S)-Leucine; (2S)-2-amino-4-methylpentanoic acid; (S)-(+)-Leucine; Leucin; L-Norvaline, 4-methyl-; (S)-2-Amino-4-methylvaleric acid; L-leucin; L-alpha-Aminoisocaproic acid; Leucin [German]; LEUCINE, L-; Leucine (VAN); leu; Leucinum; (2S)-alpha-leucine; L-(-)-2-Amino-4-methylpentanoic acid; 2-amino-4-methylvaleric acid; Leucinum [INN-Latin]; Leucine [USAN:INN]; L-Leuzin; Leucina [INN-Spanish]; Leucina [Latin,Spanish]; alpha-Aminoisocaproic acid

N-Methylalanine; (2S)-2-(methylamino)propanoic acid; H-N-Me-Ala-OH; Alanine, N-methyl-; L-Alanine, N-methyl-; (S)-2-(Methylamino)propanoic acid; A-Methyl-L-alanine; n-alpha-methyl-l-alanine; (S)-N-methylalanine; MFCD00037241; UNII-H5152L2RBJ; H5152L2RBJ; CHEMBL1234201; Alanine, N-methyl-, L-; N-methyl-L-alanine zwitterion; H-N-Me-D-Ala-OH; H-MeAla-OH; N-methlyalanine; N-Methyl-L-alanine hydrochloride; N-Methyl alanine; N-methyl-l-ala; L-N-Methylalanine; Methylalanine, dl-; N-Me-Ala-OH.HCl; N-Me-L-Ala; DL-Alanine, N-methyl-; SCHEMBL23315; a-(Methylamino)propionic acid; 2-(Methylamino)propionic acid; AMGLY00173; (S)-2-methylaminopropanoic acid; CTK1C2526; KS-00000GTT; KS-00000OYL; DTXSID30959936; (s)-2-methylamino-propionic acid; ZINC901468; (S)-2-(Methylamino)propionic acid; ACT06576; .alpha.-(Methylamino)propionic acid; (2S)-2-(methylamino)propionic acid; BDBM50357227; AKOS006237896; AKOS015850626; AM81482; CS-W016642; AS-18869; SC-09302; N-Methyl-L-alanine, >=98.0% (TLC); AB0030777; M2436; X3012; C02721; M-3645; 913M675; A832575; Q27102436; UNII-FER5I9LLG2 component GDFAOVXKHJXLEI-VKHMYHEASA-N

D-pipecolic acid; D-Pipecolinic acid; D-Homoproline; d(+)-pipecolinic acid; (2R)-piperidine-2-carboxylic acid; (D)-PIPECOLIC ACID; (+)-Pipecolic acid; h-d-hopro-oh; h-d-homopro-oh; 2-Piperidinecarboxylic acid, (2R)-; UNII-XPO6784Z20; (R)-pipecolic acid; (R)-Pipecolinic acid; D-(+)-Pipecolic acid; MFCD00064346; 6-CARBOXYPIPERIDINE; (r)-(+)-pipecolic acid; (d)-(+)-pipercolic acid; D-piperidine-2-carboxylic acid; CHEMBL1231898; XPO6784Z20; Pipecolic acid, (+)-; D-(+)-Pipercolic acid; d-(+)-pipecolinic acid; acidepipecolique; (2R)-2-Piperidinecarboxylic acid; EINECS 217-024-4; D-hPro-OH; PubChem5635; (+)-Pipecolinic acid; (+)-d-pipecolinic acid; D-(+)- Pipecolic acid; D-Pipecolinic acid, 99%; SCHEMBL58642; KSC178Q3T; (2r)-(+)-pipecolinic acid; (R)-(+/-)-Nipecotic acid; D(+)-Pipecolinic acid, 99%; (R)-2-Piperidinecarboxylic acid; (R)piperidine-2-carboxylic acid; CTK0H8839; 2-(R)-piperidine carboxylic acid; ZINC157014; 2 -(R)-piperidine carboxylic acid; 2-Piperidinecarboxylicacid, (2R)-; ACT07350; CS-D1144; HY-Y0181; (R)-()-2-Piperidinecarboxylic acid; ANW-22571; BDBM50357228; AKOS005258386; AKOS006238612; AC-2836; DS-1095; (2r)-(+)-2-piperidinecarboxylic acid; AC-15333; AC-16524; BR-44408; SC-01680; AB0015128; AM20090026; P1830; 723P008; Q-102967; Q27104476; UNII-H254GW7PVV component HXEACLLIILLPRG-RXMQYKEDSA-N

CHEMBL1311694; (1R,2S,5S)-REL-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXYLIC ACID; cis-3,4-methano-l-proline; MLS000736076; SCHEMBL422735; (1R,2S,5S)-Rel-3-Azabicyclo-[3.1.0]hexane-2-carboxylic acid; CTK8C0591; DTXSID90454134; HMS2643D11; ZINC3884558; ANW-64935; BDBM50357218; MFCD05663832; AKOS006238147; PB24875; SS-4355; SMR000338626; AB0093683; CS-0029924; Q-4500; (1R,2S,5S)-3-azoniabicyclo[3.1.0]hexane-2-carboxylate; (2S)-3alpha,4alpha-Methanopyrrolidine-2alpha-carboxylic acid; (1R,2S,5S)-3-azabicyclo[3.1.0]hexane-2-carboxylic acid >99%ee

h-d-cis-hyp-oh; (2R,4R)-4-hydroxypyrrolidine-2-carboxylic acid; D-cis-Hydroxyproline; (4R)-4-hydroxy-D-proline; D-PROLINE, 4-HYDROXY-, (4R)-; cis-4-hydroxy-d-prolin; MFCD00005252; CHEMBL1229563; (2r,4r)-4-hydroxy-pyrrolidine-2-carboxylic acid; cis-4-Hydroxy-D-proline, 99%; cis-4-hydroxy-D-proline zwitterion; D-allo-Hydroxyproline; (R)-allo-Hydroxyproline; 4-Hydroxy-D-alloproline; h-d-cishyp-oh; EINECS 219-963-5; NSC 524341; d-cis-4-hydroxyproline; PubChem12607; cis4-hydroxy-D-proline; 4beta-Hydroxy-D-proline; cis-4-Hydroxy-DL-proline; cis-4-hydroxy-(D)-proline; SCHEMBL85624; KSC495G2F; CTK3J5322; DTXSID20180494; ZINC895455; ACT02234; ANW-25826; BDBM50357230; s3367; AKOS000279991; AKOS005258604; AB00391; CS-W008129; HY-W008129; AS-12556; BR-46403; SC-09595; AB0012127; cis-4-hydroxy-pyrrolidine-2-carboxylic acid; AM20090318; FT-0601717; B-1565; C03440; 4-(R)-hydroxypyrrolidine-2-(R)-carboxylic acid; (2R,4R)-4-hydroxy pyrrolidine-2-carboxylic acid; 584H716; W-107214; Q27101809; cis-4-Hydroxy-D-proline, Vetec(TM) reagent grade, 98%; (2R,4R)-(+)-4-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID

(R)-Vigabatrin; R-(-)-Vigabatrin; (R)-4-Aminohex-5-enoic acid; UNII-ODN92S847A; ODN92S847A; CHEMBL1361446; (4R)-4-aminohex-5-enoic acid; (-)-gamma-Vinyl GABA; RMI 71894; R-Vigabatrin; 5-Hexenoic acid, 4-amino-, (4R)-; Tocris-0808; Lopac-V-8261; SCHEMBL9132153; R(-)-GAMMA-VINYL GABA; (4R)-4-azaniumylhex-5-enoate; DTXSID30227925; ZINC403618; BDBM50357219; MFCD00274077; NCGC00016087-01; NCGC00016087-02; NCGC00016895-01; NCGC00024802-01; Q27285598; UNII-GR120KRT6K component PJDFLNIOAUIZSL-YFKPBYRVSA-N

(S)-4-Aminoisoxazolidin-3-one; Levcycloserine; Levcicloserina; Levcycloserinum; Cyclo-L-serine; UNII-AK7DRB7FMO; (S)-4-Amino-3-isoxazolidinone; L-4-Aminoisoxazolidin-3-one; (4S)-4-amino-1,2-oxazolidin-3-one; AK7DRB7FMO; L-4-Amino-3-isoxazolidinone; (S)-(-)-Cycloserine; (4S)-4-aminoisoxazolidin-3-one; L-Oxamicina [Italian]; Levcycloserine [USAN:INN]; Levcycloserinum [INN-Latin]; Levcicloserina [INN-Spanish]; EINECS 206-427-0; L-Oxamicina; (R)-4-AMINOISOXAZOLIDIN-3-ONE; (-)-cycloserine; BRN 0080799; (-)-4-Amino-3-isossazolidone [Italian]; (S)-4-Amino-3-isoxazolidone; L-Cycloserin; (-)-4-Amino-3-isossazolidone; 3-Isoxazolidinone, 4-amino-, (S)-; 3-ISOXAZOLIDINONE, 4-AMINO-, (L)-; 3-Isoxazolidinone, 4-amino-, (4S)-; Cycloserine Impurity 4; Prestwick0_001086; Prestwick1_001086; Prestwick2_001086; Prestwick3_001086; Levcycloserine (USAN/INN); Lopac0_000199; BSPBio_001132; 4-27-00-05550 (Beilstein Handbook Reference); MLS000859981; SCHEMBL243772; SPBio_003026; BPBio1_001246; CHEMBL448864; GTPL9488; (-)-4-amino-3-isoxazolidinone; (-)-4-aminoisoxazolidin-3-one; CTK8B7665; KS-00000NWI; (S)-4-amino-isoxazolidin-3-one; DTXSID701017231; HMS1571I14; HMS2098I14; HMS2235N07; HMS3260H19; HMS3264E06; HMS3715I20; (S)-3-Isoxazolidinone, 4-amino-; ACT10801; HY-B1122; Tox21_500199; 4034AB; ANW-58103; BDBM50357231; FD3007; MFCD00064324; s3945; SBB006706; ZINC34676244; AKOS006237181; CCG-204294; CS-4717; LP00199; SDCCGSBI-0050187.P002; NCGC00093674-01; NCGC00093674-02; NCGC00093674-03; NCGC00093674-04; NCGC00093674-08; NCGC00260884-01; DS-18395; SMR000326840; AB0006204; AB00514038; EU-0100199; L-Cycloserine, L-4-Amino-3-isooxazolidinone; (4S)-4-amino-2,4,5-trihydroisoxazol-3-one; (S)-4-Amino-3-isoxazolidone;(S)-Cycloserine; C 1159; D04706; AB00514038_05; 339C720; SR-01000780566; J-502461; SR-01000780566-2; Q27145415

(R)-Thiazolidine-4-carboxylic acid; L-Thiaproline; Thioproline; L-Thiazolidine-4-carboxylic acid; H-Thz-OH; (4R)-1,3-thiazolidine-4-carboxylic acid; L-4-Thiazolidinecarboxylic acid; (R)-4-Thiazolidinecarboxylic acid; 4-thiaproline; gamma-thioproline; (4R)-4-Thiazolidinecarboxylic acid; 4-Thiazolidinecarboxylic acid, (4R)-; (R)-(-)-4-Thiazolidinecarboxylic acid; Thiazolidinecarboxylic acid; (R)-(-)-Thiazolidine-4-carboxylic Acid; UNII-KL096K0KXL; (R)-timonacic; MFCD00005212; KL096K0KXL; 34592-47-7 (R-isomer); D-Thiazolidine-4-carboxylic acid; NCGC00166087-01; L(-)-Thiazolidine-4-carboxylic acid; DSSTox_CID_26536; DSSTox_RID_81700; DSSTox_GSID_46536; Thioproline, L-; CCRIS 3646; L(-)-Thiazolidine-4-carboxylic acid, 98%; EINECS 252-106-3; L-4-Thiazolidinecarboxylic acid, 98%; H-Thiopro-OH; (4R)-thiazolidine-4-carboxylic acid; 4-Thiazolidinecarboxylic acid, (R)-; cis-4-thia-l-proline; SCHEMBL609164; CHEMBL1235440; DTXSID3046536; CTK1C2984; ZINC967473; Tox21_112310; ANW-47015; BDBM50357232; SBB015063; 4-Thiazolidinecarboxylicacid, (4R)-; AKOS016346321; Tox21_112310_1; AC-9027; AM81428; CS-W013392; DB02846; FS-3979; L-(-)-Thiazolidine-4-carboxylic acid; NE10386; KS-00000G49; NCGC00263468-01; (R)-1,3-Thiazolidine-4-carboxylic acid; SC-77532; ST075168; T-2900; Q27093808; F1905-7154; UNII-E5913T3IBL component DZLNHFMRPBPULJ-VKHMYHEASA-N

(S)-Piperidine-2-carboxylic acid; l(-)-pipecolinic acid; L-Homoproline; h-hopro-oh; L-pipecolate; L-Pipecolinic acid; (2S)-piperidine-2-carboxylic acid; (l)-pipecolic acid; 2-Piperidinecarboxylic acid, (2S)-; L-(-)-Pipecolinic acid; (S)-pipecolic acid; (-)-Pipecolic acid; l-piperidine-2-carboxylic acid; (S)-(-)-2-Piperidinecarboxylic acid; L-(-)-pipecolic acid; h-homopro-oh; UNII-69374CKB33; EINECS 221-462-1; (-)-(S)-pipecolic acid; (S)-(-)-pipecolic acid; 69374CKB33; (S)-pipecolate; L-pipecolic acid zwitterion; Pipecolic acid, (-)-; MFCD00005981; D-(+)-Pipercolic acid; (S)-2-Piperidinecarboxylic acid; l-homopro; L-Pipecolinate; (S)-Pipecolinate; (-)-Pipecolate; NSC 93089; L-(-)-Pipecolate; PubChem5567; (S)-Pipecolinic acid; (S)-(-)-Pipecolate; (-)-l-pipecolinic acid; s-(-)-pipecolinic acid; bmse000237; L-Piperidine-2-carboxylate; (S)-2-Piperidinecarboxylate; SCHEMBL40185; KSC223E5T; (2s)-(-)-pipecolinic acid; (S)-piperidine-2-carboxylate; s-piperidine-2-carboxylic acid; 2(S)-Piperidinecarboxylic acid; CHEMBL322883; CTK1C3259; (2S)piperidine-2-carboxylic acid; ZINC157015; (S)-(-)-2-Piperidinecarboxylate; 2-Piperidinecarboxylicacid, (2S)-; ACT07825; Pipecolic acid, L-(-)- (8CI); (S)(-)-2-piperidinecarboxylic acid; ANW-43628; CP0058; L-Pipecolic acid, 99% (titration); s6302; SBB006732; AKOS005258385; AB00554; CS-W013450; EBD2156810; HY-W012734; LS30195; MCULE-9674307172; AM803674; BR-44409; DS-13286; L-Pipecolic acid, Proline homolog., 99%; 2-Piperidinecarboxylic acid, (S)- (9CI); AB0006104; P1404; EN300-66085; (S)-(-)-PIPERIDINE-2-CARBOXYLIC ACID; C00408; K-7385; L-Pipecolic acid, puriss., >=99.0% (NT); 105P951; Q-103016; Q27104171; 7C6A2DED-5E15-4DFB-BF48-F9D231169779; Z1270387296; UNII-H254GW7PVV component HXEACLLIILLPRG-YFKPBYRVSA-N

m-Aminobenzoic acid; Benzoic acid, 3-amino-; m-Carboxyaniline; 3-Carboxyaniline; Benzoic acid, m-amino-; Aniline-3-carboxylic acid; meta-aminobenzoic acid; MFCD00007795; m-Aminobenzoesaeure; UNII-G2X3B3O37U; 3-Aminobenzoesaeure; 3-Amino-Benzoic Acid; MLS000069458; CHEMBL307782; G2X3B3O37U; SMR000059135; 3-Aminobenzoic acid, 98%; 3-Aminobenzoic acid, 99+%; EINECS 202-724-4; NSC 15012; BRN 0471603; M-Amonibenzoate; AI3-04707; 3-Aminobenzoesure; m-aninobenzoic acid; M-Amonibenzoic acid; Benzoic acid, 3-amino-, ion(1-); m-amino benzoic acid; 3-amino benzoic acid; Aniline-3-carboxylate; 3-anilinecarboxylic acid; Opera_ID_150; aminobenzenecarboxylic acid; WLN: ZR CVQ; H-(3)Abz-OH; Oprea1_172994; SCHEMBL27648; 4-14-00-01092 (Beilstein Handbook Reference); KSC201Q0P; MLS001076476; DTXSID3059183; HMS2236H06; HMS3369J18; ZINC388179; ACMC-209794; KS-000000FV; NSC15012; STR00672; ANW-13670; BBL037339; BDBM50226518; NSC-15012; SBB028148; STK301688; AKOS000119015; AS00862; CS-W019987; DB02054; MCULE-8263489676; NCGC00018151-01; NCGC00018151-02; NCGC00018151-03; AK-41177; BR-41177; SC-16197; SY001800; DB-022255; A0268; AM20050192; FT-0615027; ST45061462; M-5857; 122900-EP2292589A1; 122900-EP2295053A1; 147527-EP2281563A1; 147527-EP2292589A1; Q223045; 3-Aminobenzoic acid, Vetec(TM) reagent grade, 98%; Q-200359; F2191-0235

1-Methylglycocyamidine; 1-Methylhydantoin-2-imide; 4H-Imidazol-4-one, 2-amino-1,5-dihydro-1-methyl-; 2-amino-1-methylimidazolin-4-one; Kreatinin; 2-Imino-N-methylhydantoin; Creatine anhydride; 2-Amino-1-methyl-2-imidazolin-4-one; 2-amino-1-methyl-1,5-dihydro-4H-imidazol-4-one; 2-Amino-1,5-dihydro-1-methyl-4H-imidazol-4-one; Creatinine, 98%; NSC-13123; NCGC00095762-01; DSSTox_CID_25987; DSSTox_RID_81274; DSSTox_GSID_45987; 4H-Imidazol-4-one, 2-imino-1,5-dihydro-1-methyl-; creatinina; Spectrum_000429; Spectrum2_000764; Spectrum3_001717; Spectrum4_001806; Spectrum5_000511; bmse000155; bmse000789; bmse001001; SCHEMBL16295; BSPBio_003334; KBioGR_002415; KBioSS_000909; MLS001306430; CHEMBL65567; DivK1c_000351; SPECTRUM1600300; SPBio_000808; Creatinine, anhydrous, >=98%; CTK5E9313; HMS501B13; KBio1_000351; KBio2_000909; KBio2_003477; KBio2_006045; KBio3_002554; NINDS_000351; Creatinine, 98.5-102.0%; HMS2233P20; HMS3372L11; Pharmakon1600-01600300; ZINC967189; KS-00000DF8; Tox21_111516; BBL009279; CCG-40153; KM0389; NSC760435; s3102; STK530885; STL268897; 2-Imino-1-methyl-imidazolidin-4-one; AKOS000121140; AKOS005458367; Tox21_111516_1; 2-Imino-1-methyl-4-imidazolidinone #; Creatinine, NIST(R) SRM(R) 914a; MCULE-8832153777; NSC-760435; SDCCGMLS-0066864.P001; IDI1_000351; NCGC00095762-02; NCGC00095762-04; NCGC00247664-01; 4H-Imidazol-4-one,5-dihydro-1-methyl-; AS-12671; SC-16445; SMR000718791; AB0012307; 2-Amino-1-methyl-1,5-dihydroimidazol-4-one; 2-amino-1-methyl-1,5-dihydro-imidazol-4-one; C00791; D03600; 92630-EP2277858A1; 92630-EP2292227A2; 92630-EP2295053A1; 92630-EP2305653A1; AB00052404_03; AB00052404_04; 059C730; 2-amino-4,5-dihydro-1-methyl-1H-imidazol-4-one; 2-Imino-1,5-dihydro-1-methyl-4H-imidazol-4-one; SR-01000837526; SR-01000837526-3; W-203248; F0001-1578; C5CF605C-9352-48F2-A5A4-561B97D42C30; Creatinine, United States Pharmacopeia (USP) Reference Standard; Creatinine, Pharmaceutical Secondary Standard; Certified Reference Material

2-Picolinic acid; 2-Pyridinecarboxylic acid; Pyridine-2-carboxylic acid; 2-Carboxypyridine; o-Pyridinecarboxylic acid; alpha-Picolinic acid; PYRIDINECARBOXYLIC ACID; alpha-Pyridinecarboxylic acid; Acide picolique; Pyridine-carboxylique-2; MFCD00006293; NSC 171; 2-pyridine carboxylic acid; UNII-QZV2W997JQ; AI3-19242; Pyridinecarboxylic acid-(2); QZV2W997JQ; Picolinic acid 99% solution; CHEMBL72628; .alpha.-Pyridinecarboxylic acid; PCL 016; NCGC00165993-01; Picolinic acid, 99%; Nicogamol; Nikogamol; 2-pyridinecarboxylate; DSSTox_CID_11903; DSSTox_RID_78896; DSSTox_GSID_31903; Acide picolique [French]; SMR000814709; NSC21209; Pyridine-carboxylique-2 [French]; EINECS 202-719-7; NSC 21209; BRN 0109595; picolinicacid; picolic acid; CCRIS 8307; 2-picolic acid; A-Picolinic acid; PubChem9774; pyridine carboxylic acid; pyridine-carboxylic acid; ACMC-20aiw6; 2-pyridincarboxylic acid; pyridinium 2-carboxylate; a-Pyridinecarboxylic acid; 2-pyridine carboxic acid; Pyridine-A-carboxylic acid; 2-pyridine-carboxylic Acid; Oprea1_485360; SCHEMBL36055; 5-22-02-00003 (Beilstein Handbook Reference); KSC225M4F; MLS001335931; MLS001335932; Picolinic acid (PCL 016); Phenyl-(2-pyridyl)acetonitrile; NSC171; DTXSID7031903; CTK1C5642; SIOXPEMLGUPBBT-UHFFFAOYSA-; ZINC39905; HMS2232K05; BCP26613; CS-D1196; HY-I0660; STR00111; Tox21_112282; Tox21_202953; ANW-75412; BBL025950; BDBM50000407; HTS006384; s6249; SBB004277; STL164340; AKOS000119032; Tox21_112282_1; AB00685; AC-2105; AM81303; MCULE-1025041475; PS-4253; NCGC00165993-02; NCGC00260499-01; 2-Picolinic acid, ReagentPlus(R), 99%; AK-50286; AT-19428; BP-13036; BP-21456; BR-50286; NCI60_001382; SC-07528; SY001169; AB0007854; DB-014967; 757-EP2374895A1; FT-0608336; P0421; ST50213873; C10164; M-5996; 11473-EP2308847A1; 11473-EP2316827A1; 31522-EP2269992A1; 31522-EP2270895A2; 31522-EP2278637A1; 31522-EP2308858A1; 31522-EP2311816A1; 31522-EP2311817A1; 33091-EP2270895A2; 33091-EP2272848A1; 33091-EP2278637A1; 33091-EP2295429A1; 33091-EP2311815A1; 2-Picolinic acid, Vetec(TM) reagent grade, 98%; Q416682; C9DF3EBC-98F0-4165-BE9A-92F8EE33CDBA; W-100058; Z57968195; F2191-0113

(2S,4S)-4-hydroxypyrrolidine-2-carboxylic acid; cis-4-hydroxyproline; (4S)-4-hydroxy-L-proline; L-Proline, 4-hydroxy-, (4S)-; L-Hydroxyproline; allo-4-Hydroxy-L-proline; L-cis-4-hydroxyproline; L-Allohydroxyproline; UNII-43V78B6A3B; L-allo-hydroxyproline; cis-Hydroxyproline; 4-cis-L-hydroxyproline; Cis -4-hydroxy-L-proline; 4-hydroxyproline; CHEMBL1233477; 43V78B6A3B; allo-4-Hydroxyproline; MFCD00064319; L-Proline, allo-hydroxy-; Hydroxy-L-Proline [Allo]; (2S,4S)-4-hydroxy-2-pyrrolidinecarboxylic acid; NSC 206274; Hydroxyproline cis-form; cis -4-Hydroxy-D-proline; MFCD00064320; EINECS 210-542-1; cis-L-hydroxyproline; (4s)-hydroxyproline; zlchem 1205; PubChem10982; PubChem12571; SCHEMBL19307; CTK3J1665; DTXSID20883473; ZLD0674; ZINC901736; ACN-S002988; ACT02235; ANW-33952; BDBM50357209; KM0546; AKOS016015787; AC-2250; AC-3101; CS-W009077; MB00510; KS-00000K44; L-Proline, 4-hydroxy-, cis- (9CI); Proline, 4-allo-hydroxy-, L- (8CI); AM808165; AS-15085; cis-4-Hydroxypyrrolidine-2-carboxylic acid; C01015; 618H279; Q-200862; (2S,4S)-4-hydroxypyrrolidine-2-carboxylic acid HCl; cis-4-Hydroxy-L-proline, collagen synthesis inhibitor; Q27103674; cis-4-Hydroxy-L-proline, Vetec(TM) reagent grade, 98%; F8880-8952; (2S,4S)-(-)-4-HYDROXY-2-PYRROLINECARBOXYLIC ACID; (2S,4S)-(-)-4-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID; Cis-4-Hydroxy-L-proline(2S,4S)-4-Hydroxypyrrolidine-2-carboxylic Acid

(2S,3S)-3-Hydroxypyrrolidine-2-carboxylic acid; (3S)-3-hydroxy-L-proline; L-Proline, 3-hydroxy-, (3S)-; 3-Hydroxyproline; trans-3-Hydroxypyrrolidine-2-carboxylic acid; trans-L-3-Hydroxyproline; CHEMBL1233466; (2S,3S)-(-)-3-Hydroxy-L-proline; trans-3-Hydroxyproline; trans-3-hydroxy-L-proline zwitterion; MFCD00216471; (+)-cis-(2R,3S)-3-hydroxyproline; DL-trans-Hydroxyproline; trans-3-hydroxy-l -proline; (2S,3S)-3-hydroxyproline; SCHEMBL114870; trans-3-Hydroxy (L)-proline; trans-3-hydroxy-(L)-proline; Proline, 3-hydroxy-, trans-; 3-Hydroxy-L-proline, (3S)-; L-3-TRANS-HYDROXYPROLINE; CTK7F3128; Proline, 3-hydroxy-, L-trans-; DTXSID701009886; ZINC4096639; BDBM50357213; AKOS006237683; AKOS007929922; CS-W006575; PB33863; QC-5005; DS-13740; SC-21947; ST51037618; KS-00000470; C05147; Q-2452; trans-3-Hydroxy-L-proline, >=98.0% (NT); (2S,3R);-3-Hydroxypyrrolidine-2-carboxylic acid; (2S,3S)-3-Hydroxy-pyrrolidine-2-carboxylic acid; Q23804983; 8FFC3DF8-29A2-44A6-A1DF-529FE41020F0; UNII-425I4Y24YZ component BJBUEDPLEOHJGE-IMJSIDKUSA-N; UNII-62GP7W651S component BJBUEDPLEOHJGE-IMJSIDKUSA-N; UNII-8ZWY97A2NG component BJBUEDPLEOHJGE-IMJSIDKUSA-N; UNII-SZB83O1W42 component BJBUEDPLEOHJGE-IMJSIDKUSA-N

Tetrahydropyrrole; Tetrahydro pyrrole; Azacyclopentane; Azolidine; Tetramethylenimine; Butylenimine; Perhydropyrrole; Prolamine; 1-Azacyclopentane; Tetramethyleneimine; Pyrrole, tetrahydro-; Pyrrolidine ring; pyrrolidin; UNII-LJU5627FYV; NSC 62781; MFCD00005249; LJU5627FYV; CHEMBL22830; Pyrrolidine, 99+%; FEMA No. 3523; CCRIS 6688; HSDB 120; EINECS 204-648-7; UN1922; BRN 0102395; pyrolidine; pyrollidine; pyrroldine; pyrrolodine; Pirrolidine; Pyrrollidine; AI3-24117; (s)-pyrrolidine; 14-pyrrolidine; Pyrrolidine, FG; Pyrrolidine, 99%; Pyrrolidinepyrrolidine; 1$l^{2}-azolidine; PubChem19143; ACMC-209aps; Pyrrolidine, >=99%; WLN: T5MTJ; EC 204-648-7; NCIOpen2_007788; 1,2,3,4-tetrahydropyrrole; 1,2,3,5-tetrahydropyrrole; UPCMLD00WV-121; 5-20-01-00162 (Beilstein Handbook Reference); KSC176K5J; pyrrolidine LT phase at 135K; pyrrolidine LT phase at 205K; DTXSID3059559; CTK0H6554; FEMA 3523; Pyrrolidine - HT phase at 165K; Pyrrolidine - HT phase at 207K; KS-00000Z0V; NSC62781; STR00030; ZINC1690615; ANW-18158; BDBM50026437; NSC-62781; STL182845; AKOS000119098; PYRROLIDINE (TETRAHYDROPYRROLE); MCULE-2816679267; UN 1922; Pyrrolidine, puriss. p.a., >=99.0%; Pyrrolidine, analytical reference material; SC-25699; 2,3,4,5-tetrahydropyrrol-4-ylium-1-ide; AB0105730; DB-000672; FT-0658759; P0576; Pyrrolidine - low temperature phase at 135K; Pyrrolidine - low temperature phase at 205K; Pyrrolidine [UN1922] [Flammable liquid]; Pyrrolidine - high temperature phase at 165K; Pyrrolidine - high temperature phase at 207K; 3941-EP2269977A2; 3941-EP2269983A1; 3941-EP2269984A1; 3941-EP2269990A1; 3941-EP2269993A1; 3941-EP2270003A1; 3941-EP2270004A1; 3941-EP2270006A1; 3941-EP2270010A1; 3941-EP2270113A1; 3941-EP2272509A1; 3941-EP2272517A1; 3941-EP2272813A2; 3941-EP2272817A1; 3941-EP2272825A2; 3941-EP2272832A1; 3941-EP2272841A1; 3941-EP2272935A1; 3941-EP2272972A1; 3941-EP2272973A1; 3941-EP2274983A1; 3941-EP2275102A1; 3941-EP2275395A2; 3941-EP2275401A1; 3941-EP2275404A1; 3941-EP2275411A2; 3941-EP2275412A1; 3941-EP2275421A1; 3941-EP2275422A1; 3941-EP2275424A1; 3941-EP2277848A1; 3941-EP2277858A1; 3941-EP2277867A2; 3941-EP2277872A1; 3941-EP2277880A1; 3941-EP2280001A1; 3941-EP2280003A2; 3941-EP2280005A1; 3941-EP2280006A1; 3941-EP2280008A2; 3941-EP2280009A1; 3941-EP2280978A1; 3941-EP2281563A1; 3941-EP2281813A1; 3941-EP2281815A1; 3941-EP2281818A1; 3941-EP2281819A1; 3941-EP2281821A1; 3941-EP2281822A1; 3941-EP2284157A1; 3941-EP2286811A1; 3941-EP2287153A1; 3941-EP2287167A1; 3941-EP2288605A1; 3941-EP2289871A1; 3941-EP2289884A1; 3941-EP2289887A2; 3941-EP2289888A2; 3941-EP2289892A1; 3941-EP2289893A1; 3941-EP2292586A2; 3941-EP2292592A1; 3941-EP2292593A2; 3941-EP2292595A1; 3941-EP2292606A1; 3941-EP2292610A1; 3941-EP2292611A1; 3941-EP2292613A1; 3941-EP2292619A1; 3941-EP2292630A1; 3941-EP2294063A1; 3941-EP2295399A2; 3941-EP2295402A2; 3941-EP2295406A1; 3941-EP2295411A1; 3941-EP2295418A1; 3941-EP2295426A1; 3941-EP2295427A1; 3941-EP2295429A1; 3941-EP2295432A1; 3941-EP2295433A2; 3941-EP2297098A1; 3941-EP2298729A1; 3941-EP2298731A1; 3941-EP2298735A1; 3941-EP2298743A1; 3941-EP2298761A1; 3941-EP2298763A1; 3941-EP2298764A1; 3941-EP2298765A1; 3941-EP2298766A1; 3941-EP2298767A1; 3941-EP2298772A1; 3941-EP2298776A1; 3941-EP2298778A1; 3941-EP2301533A1; 3941-EP2301534A1; 3941-EP2301627A1; 3941-EP2301923A1; 3941-EP2301928A1; 3941-EP2301929A1; 3941-EP2301935A1; 3941-EP2302132A1; 3941-EP2305219A1; 3941-EP2305250A1; 3941-EP2305648A1; 3941-EP2305651A1; 3941-EP2305657A2; 3941-EP2305659A1; 3941-EP2305672A1; 3941-EP2305674A1; 3941-EP2305682A1; 3941-EP2305687A1; 3941-EP2305695A2; 3941-EP2305696A2; 3941-EP2305697A2; 3941-EP2305698A2; 3941-EP2308510A1; 3941-EP2308562A2; 3941-EP2308812A2; 3941-EP2308838A1; 3941-EP2308839A1; 3941-EP2308840A1; 3941-EP2308847A1; 3941-EP2308851A1; 3941-EP2308854A1; 3941-EP2308857A1; 3941-EP2308867A2; 3941-EP2308870A2; 3941-EP2308872A1; 3941-EP2308879A1; 3941-EP2311451A1; 3941-EP2311464A1; 3941-EP2311796A1; 3941-EP2311797A1; 3941-EP2311798A1; 3941-EP2311799A1; 3941-EP2311802A1; 3941-EP2311803A1; 3941-EP2311810A1; 3941-EP2311811A1; 3941-EP2311814A1; 3941-EP2311815A1; 3941-EP2311818A1; 3941-EP2311823A1; 3941-EP2311824A1; 3941-EP2311825A1; 3941-EP2311829A1; 3941-EP2311831A1; 3941-EP2311836A1; 3941-EP2311840A1; 3941-EP2311850A1; 3941-EP2314295A1; 3941-EP2314574A1; 3941-EP2314575A1; 3941-EP2314586A1; 3941-EP2314587A1; 3941-EP2314590A1; 3941-EP2315303A1; 3941-EP2316450A1; 3941-EP2316470A2; 3941-EP2316829A1; 3941-EP2316831A1; 3941-EP2316832A1; 3941-EP2316833A1; 3941-EP2316974A1; 3941-EP2371811A2; 3941-EP2371831A1; 3941-EP2372804A1; 3941-EP2374454A1; 3941-EP2378585A1; 5258-EP2270010A1; 5258-EP2272972A1; 5258-EP2272973A1; 5258-EP2277872A1; 5258-EP2284149A1; 5258-EP2292593A2; 5258-EP2305669A1; 5258-EP2308868A1; 108957-EP2275422A1; 108957-EP2284166A1; 108957-EP2292589A1; 108957-EP2298769A1; A805120; Pyrrolidine, >=99.5%, purified by redistillation; Q408898; Z57834050; F2190-0325

1,3-Thiazolidine; Tetrahydrothiazole; 1-Thia-3-azacyclopentane; Thiazole, tetrahydro-; UNII-I320806BKW; MFCD00005211; CHEMBL1916078; I320806BKW; Thiazolidine, 98%; CCRIS 4275; EINECS 208-002-5; BRN 0102469; NSC357911; Thiazolidine, 95%; 1,3-Thiazolidine #; ACMC-1AO0M; 1,3$l^{2}-thiazolidine; 4-27-00-00009 (Beilstein Handbook Reference); DTXSID10198447; ALBB-022614; BCP22810; KS-00000WB3; STR04848; ZINC1584141; ANW-75639; BDBM50357214; AKOS005146302; MCULE-8646299838; NSC-357911; SC-91699; CS-0006687; R1117; ST51041175; X5560; 25688-EP2269990A1; 25688-EP2270010A1; 25688-EP2275404A1; 25688-EP2275411A2; 25688-EP2275412A1; 25688-EP2281818A1; 25688-EP2287152A2; 25688-EP2292589A1; 25688-EP2292593A2; 25688-EP2292611A1; 25688-EP2295406A1; 25688-EP2298731A1; 25688-EP2298735A1; 25688-EP2308510A1; 25688-EP2308562A2; 25688-EP2308857A1; 25688-EP2314575A1; 25688-EP2315303A1; 25688-EP2371811A2; 25688-EP2374454A1; 54052-EP2281818A1; 54052-EP2308510A1; 54052-EP2308562A2; 54052-EP2371811A2; 186674-EP2270006A1; 186674-EP2270113A1; 186674-EP2272935A1; Q413761

L-norvaline; (S)-2-Aminopentanoic acid; h-nva-oh; (2S)-2-aminopentanoic acid; L-2-aminopentanoic acid; L-2-Aminovaleric acid; (S)-2-Aminovaleric acid; UNII-A70UKS48FE; 2-Aminovaleric acid; Norvaline, L-; l-(+)-norvaline; 2S-amino-pentanoic acid; MFCD00064421; A70UKS48FE; Valeric acid, 2-amino-; Pentanoic acid, 2-amino-; L(+)-Norvaline, 99%; L(+)-Norvaline; 2-AMINO-PENTANOIC ACID; Norvaline (VAN); L-2-aminopentanoic acid zwitterion; alpha-L-Aminopentanoic acid; norvalin; Pentanoic acid, 2-amino-, (S)-; EINECS 229-543-3; NSC 203786; PubChem5727; L-Norvaline (9CI); SCHEMBL38405; (S)-2-amino-pentanoic acid; (2S)-2-azanylpentanoic acid; CHEMBL55612; L-Norvaline, arginase inhibitor; CTK2F3175; KS-00000AAU; DTXSID701018015; ZINC391821; CS-D1371; HY-Y0399; KS-00000A8O; ANW-35129; BDBM50357215; LMFA01100041; AKOS006240270; AB02603; DB04185; LS30304; AC-12879; AC-31149; AS-13576; BR-44188; SC-06139; AB0013881; AM20100599; N0686; C01826; M-3555; N-9040; 33778-EP2275102A1; 33778-EP2277865A1; 33778-EP2277867A2; 33778-EP2280003A2; 33778-EP2295055A2; 33778-EP2311453A1; 178647-EP2270002A1; 600N404; A835303; Q418707; Z1741968246; UNII-V639KTF2SZ component SNDPXSYFESPGGJ-BYPYZUCNSA-N; 9555A1CC-4DD7-41F1-9133-98A0F33A16A6

L-(+)-Prolinol; (S)-PYRROLIDIN-2-YLMETHANOL; (S)-(+)-2-Pyrrolidinemethanol; [(2S)-pyrrolidin-2-yl]methanol; (S)-PROLINOL; (2S)-pyrrolidin-2-ylmethanol; (S)-(+)-2-(Hydroxymethyl)pyrrolidine; (S)-(+)-Prolinol; Prolinol; L(+)-Prolinol; MFCD00005255; 2-PYRROLIDINEMETHANOL, (2S)-; H-PRO-OL; (-)-L-PROLINOL; CHEMBL1916080; (S)-1-pyrrolidin-2-yl-methanol; (2S)-2-PYRROLIDINEMETHANOL; (S)-2-HYDROXYMETHYLPYRROLIDINE; L(+)-Prolinol, 95%; (S)-(+)- Prolinol; Pro-ol; H-Prolinol(oil); (L)-prolinol; PubChem6910; (S)-2pyrrolidinemethanol; 2-(S)-pyrrolidinemethanol; (S)pyrrolidin-2-ylmethanol; (S)-2-pyrrolidine methanol; (2s)-2-pyrrolidinylmethanol; 2(s)-hydroxymethylpyrrolidine; KSC201S9H; (2S)-pyrrolidine-2-methanol; SCHEMBL115932; (S)-pyrrolidin-2-yl-methanol; [(2S)-2-pyrrolidinyl]methanol; (2S)-2-hydroxymethylpyrrolidine; (S)-2-hydroxymethyl-pyrrolidine; 2-hydroxymethyl-(S)-pyrrolidine; CTK1A1993; (S)-2-(hydroxymethyl)pyrrolidin; (2S)-2-hydroxymethyl-pyrrolidine; (S)-2-(hydroxymethyl)pyrrolidine; (S)-2-PYRROLIDINEMETHANOL; 2-(S)-(hydroxymethyl)pyrrolidine; (s)-(+)-2-pyrrolidine methanol; (S)-(+)-2-pyrrolidine-methanol; (S)-(+)-2-pyrrolidinemethanol;; ZINC391904; (2S)-2-(hydroxymethyl)pyrrolidine; ACT04140; ALBB-021094; CS-D1460; KS-000003DS; 2-Pyrrolidinemethanol hydrochloride; (S)-(-)-pyrrolidin-2-yl-methanol; ANW-25103; BDBM50357222; EBD592895; AKOS005259889; AC-8565; AM82208; MCULE-6448856585; PB30520; PS-9388; SB10361; (S)-1-PYRROLIDIN-2-YLMETHANOL; (S)-(+)-2-Pyrrolidinemethanol, 97%; (S)-(-)-2-(hydroxymethyl)-pyrrolidine; BR-46693; SC-02696; AB0005836; EN300-70033; 56P969; C-8058; M03445; 41214-EP2301928A1; 41214-EP2308873A1; 41214-EP2311831A1; 175797-EP2275414A1; 175797-EP2287155A1; 204122-EP2277867A2; 204122-EP2280003A2; A827884; W-107405; F0001-0809; Z1263811747

D(-)-Norvaline; (2R)-2-aminopentanoic acid; H-D-Nva-OH; D-(-)-Norvaline; D-2-Aminopentanoic acid; D-2-Aminovaleric acid; (R)-2-Aminovaleric Acid; MFCD00008097; UNII-102E6YF9W5; CHEMBL1916081; (R)-2-AMINOPENTANOIC ACID; 102E6YF9W5; norvalines; 2-Aminovaleric acid; 2-aminovaleric acids; 2-aminopentanoic acids; alpha-Aminovaleric acid; (.+-.)-Norvaline; alpha-aminopentanoic acid; D-Ape; (.+/-.)-Norvaline; d-norvalin; Norvaline #; (R)-norvaline; Norvaline, D-; D-Nva; D-Norvaline, 99%; 2-Amino-DL-Valeric acid; DL-alpha -Aminovaleric acid; KSC491O6F; (2R)-2-azanylpentanoic acid; alpha -DL-Aminopentanoic acid; Norvaline (ACD/Name 4.0); SCHEMBL197812; dl-alpha-Amino-N-valenic acid; CTK3J1762; DTXSID40942157; (R)-(-)-2-Aminopentanoic acid; ZINC391822; ACT04821; EINECS 217-936-2; ANW-13677; BDBM50357223; SBB065919; AKOS016842315; AB00929; AC-24059; AS-12608; BR-41024; SC-10374; AM20090147; CS-0015963; N0673; 13N129; C01799; N-9000; A814271; Q27103908; 4E196C57-449D-4636-BBBA-8D7CF53D6B8E; Z1741970348; UNII-V639KTF2SZ component SNDPXSYFESPGGJ-SCSAIBSYSA-N

H-D-Val-OH; (R)-Valine; Valine, D-; D-2-Aminoisovaleric Acid; (R)-2-Amino-3-methylbutanoic acid; D-valin; (2R)-2-amino-3-methylbutanoic acid; NSC 20654; D-Val; UNII-Y14I1443UR; MFCD00064219; CHEMBL1232398; Y14I1443UR; (R)-2-Amino-3-methylbutyric acid; NCGC00159470-02; D-2-Amino-3-methylbutanoic acid; D-Valine, 98+%; D-2-amino-3-methylbutyric acid; EINECS 211-368-9; 2-Amino-3-methyl-butyric acid; D valine; R-Valine; zlchem 296; PubChem11138; D-Valine, >=98%; DSSTox_CID_26064; DSSTox_RID_81315; DSSTox_GSID_46064; SCHEMBL43678; KSC352S5F; DTXSID0046064; CTK2F2952; HY-N0717A; ZLC0115; ZINC896156; ACT04818; BCP10545; (2R)-2-amino-3-methylbutanoicacid; Tox21_111694; ANW-34802; BDBM50357216; KM0815; SBB006709; AKOS006240045; AKOS015841471; AB02568; AM82362; KS-00000A95; AC-24061; AS-14130; D-Valine, Vetec(TM) reagent grade, 98%; AB0007136; CS-0010218; EN300-54608; 40V686; C06417; (R)-(-)-2-AMINO-3-METHYLBUTYRIC ACID; D-Valine, suitable for cell culture, BioReagent; J-300291; Q27103152; 9040E22A-FFB5-4A57-A5DC-9F7B09E64F07; F1905-7038; UNII-4CA13A832H component KZSNJWFQEVHDMF-SCSAIBSYSA-N